title: Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.
abstract: Tyrosine kinase inhibitor treated chronic myelogenous leukemia patients with monosomy 7 arising in Philadelphia chromosome negative (Ph-) cells tend to evolve into MDS/AML. However, monosomy 7 in Ph- cells can be a transient finding, and it is not an absolute indication of the emergence of a new myeloid malignancy.
authors.affiliation: Division of Hematology Mayo Clinic Rochester Minnesota.
authors.forename: Majd D
authors.initials: MD
authors.lastname: Jawad
authors.affiliation: Division of Hematology Mayo Clinic Rochester Minnesota.
authors.forename: Ronald S
authors.initials: RS
authors.lastname: Go
authors.affiliation: Division of Laboratory Genetics Mayo Clinic Rochester Minnesota.
authors.forename: Rhett P
authors.initials: RP
authors.lastname: Ketterling
authors.affiliation: Division of Hematology Mayo Clinic Rochester Minnesota.
authors.forename: Kebede H
authors.initials: KH
authors.lastname: Begna
authors.affiliation: Division of Hematopathology Mayo Clinic Rochester Minnesota.
authors.forename: Kaaren K
authors.initials: KK
authors.lastname: Reichard
authors.affiliation: Division of Hematopathology Mayo Clinic Rochester Minnesota.
authors.forename: Min
authors.initials: M
authors.lastname: Shi
keywords: chronic myelogenous leukemia; monosomy 7